European Trial of Pirfenidone in BOS, A European Multi-center Study

NCT02262299 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Disorder Related to Lung Transplantation
CLAD, Bronchiolitis Obliterans

Interventions

DRUG: Pirfenidone
DRUG: Placebo

Sponsor

Rigshospitalet, Denmark